Author(s)

Sandrine Oziel-Taieb, Renaud Sabatier, Marine Gilabert, Sylvain Garciaz, Pauline Ries, Slimane Dermeche, Jean-Luc Raoul

Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France..

We report herein the case of a 55-year-old man who presented an acute hemolysis following a 6th cycle of FOLFOX regimen for a metastatic colorectal cancer; this patient had previously received 12 cycles in an adjuvant setting. He had presented attenuated signs during the previous cycle. This corresponded to an oxaliplatin-induced immune hemolytic anemia. This unfrequent side effect of oxaliplatin needs to be known in order to avoid severe complications.

Oxaliplatine; Hemolysis; Auto-Immune; Colorectal Cancer

S. Oziel-Taieb, R. Sabatier, M. Gilabert, S. Garciaz, P. Ries, S. Dermeche and J. Raoul, "Recurrent Oxaliplatin-Induced Immune Hemolytic Anemia by Chemotherapy for Metastatic Colon Cancer: A Case Report," Journal of Cancer Therapy, Vol. 4 No. 1, 2013, pp. 159-160. doi: 10.4236/jct.2013.41022.